MoneyWorks4Me

Sanofi India informs about issuance of duplicate share certificates

19 Jul 2023 Evaluate

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Sanofi India has informed that the Company has approved issue of duplicate share certificates requests in lieu of the original share certificates reported lost/misplaced, details of which are enclosed. Pursuant to SEBI circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January 2022 a letter of confirmation will be issued to claimants.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..